Continuous Bladder Irrigation Devices Market Size, Share, Growth - By Product, By End Use - Global Forecast, 2025 - 2034

Continuous Bladder Irrigation Devices Market Size

The global continuous bladder irrigation devices market was valued at USD 1.4 billion in 2024 and is projected to exhibit 4.4% CAGR from 2025-2034. The increasing incidence of diseases such as benign prostatic hyperplasia (BPH), bladder cancer, and hematuria necessitates added use of continuous bladder irrigation systems.
 

For instance, according to the World Health Organization (WHO), bladder cancer is the 10th most common cancer in the world, with approximately 573,000 new cases and 213,000 deaths in 2020. Such diseases need post-surgical treatment and management of urinary tract obstructions, reflecting a consistent demand for bladder irrigation devices in medical facilities.
 

The global population that is aging has led to an increasing number of elderly people who have urological disorders. The United Nations indicates that in 2050, 1 in every 6 people on the planet will be over 65 years old, as opposed to 1 in every 11 in 2019. Further, as per John Hopkins Medicine, symptoms related to BPH appear in about 1 in 4 men by age 55, and in half of the men who are 75 years old, highlighting the growing demand for regular bladder irrigation solutions in the senior category.
 

In addition, advancements in catheter material and irrigation method have improved the effectiveness, safety, and ease of bladder irrigation devices. Proper catheter care and irrigation method are highlighted by the CDC's Healthcare-associated Infections (HAI) prevention guidelines to minimize infection rates, showing the significant role of high-end irrigation devices in enhancing patient care outcome.
 

Continuous bladder irrigation (CBI) equipment is mainly applied in health facilities to treat conditions such as urinary bladder infection, bleeding, or postoperative treatment, especially after procedures such as transurethral resection of the prostate (TURP) or surgery for bladder cancer. CBI equipment is mainly Foley 3-way catheters, irrigation jugs, and equipment facilitating catheter patency, risk reduction of infection, and urine flow control. These instruments are necessary for the management of patients with hematuria (urinary bleeding), postop, or other urologic conditions that need irrigation in a bid to avert complications such as clot retention or obstruction.
 

Continuous Bladder Irrigation Devices Market Trends

• The market is moving towards smart CBI equipment that provides real-time monitoring, automated controls, and electronic health record connectivity. All these technologies are focused on improving patient outcomes by enabling healthcare professionals with timely information for decision making.
   
• Additionally, vendors are focusing towards developing small, portable CBI devices (such as compact CBI Pumps), thereby increasing their applications in various clinical settings. This development enables users to handle and use these devices with convenience, especially in home care and long-term care facilities, to improve patient mobility and comfort.
   
• More emphasis is being put on the design of CBI devices that maximize patient convenience and comfort. The technologies are such that they reduce invasiveness and make the patient experience generally more comfortable, leading to more compliance with the treatment regimen and better clinical outcomes.
   
• Furthermore, the COVID-19 pandemic elevated the importance of infection control in healthcare environments. This led to growing demand for disposable and ready-to-clean CBI devices as they reduce the risk of healthcare-related infections and ensure patient safety.
   

Trump Administration Tariffs

• The Trump administration's tariffs are expected to bring drastic dislocations into the global supply chain, primarily impacting the U.S.-based continuous bladder irrigation device companies that rely on outsourced parts from suppliers in China.
   
• Moreover, this can lead to delay in ordering of essential pieces of equipment like foley catheters, irrigation bag, tubing, and drainage bag, leading to potential bottlenecks and increased total cost of manufacture.
   
• Healthcare providers might have to pay more for CBI devices due to the rising cost of manufacturing. This can affect small-scale healthcare providers who might have limited finances.
   
• Firms can respond to the supply chain disruptions and price increases through cost optimization and diversification of the suppliers. Additionally, Chinese manufacturers might reinforce their footing in the Asian and African region with substantial untapped potential for CBI devices.
   

Continuous Bladder Irrigation Devices Market Analysis

Based on product, the market is segmented into foley 3 way catheters, accessories, and irrigation bags. The foley 3 way catheters segment is further sub-segmented into silicone catheters and latex catheters. Additionally, the accessories segment is further sub-segmented into irrigation set, roller clamp, and outlet bags. The foley 3 way catheters segment dominated the market with the largest revenue share of 58.3% in 2024.
 

• The rising prevalence of benign prostatic hyperplasia (BPH), bladder cancer, and hematuria have fueled the need for Foley 3-way catheters. For example, based on the Translational Andrology and Urology Journal, an estimated 6.4 million new cases of BPH were diagnosed worldwide in 2021. The increasing prevalence of such conditions suggests a consistent need for specialty urological devices such as Foley 3-way catheters.
   
• Further, foley 3-way catheters support concurrent drainage, irrigation, and inflation of the balloon, which are vital to post-surgical care in avoiding clotting and preserving catheter patency. This helps in increasing their adoption across post-surgical care, specifically after transurethral resection of the prostate.
   
• Apart from post-surgical care, they are applied in the treatment of trauma cases, bladder irrigation for clots, retention of urine, and post-chemotherapy care cystitis which expands their range of application across healthcare settings globally.

• The rising numbers of procedures such as transurethral resection of the prostate (TURP) and bladder tumor operations require post-operative bladder irrigation. The National Institutes of Health (NIH) estimates that about 150,000 TURP operations are carried out each year in the U.S. Continuous bladder irrigation systems are an important component in prevention of clot retention and catheter patency, which increases the success of surgery and prevention of hospital readmission. The trend reflects long-term demand for bladder irrigation devices across hospitals, hence driving the growth of the segment.
   
• Moreover, healthcare institutions focus on minimizing urinary catheter associated infections (CAUTIs) and their attendant complications. According to the International Society of Infectious Disease (ISID), catheter associated urinary tract infections (CAUTI) contribute more than 12.9% of healthcare-associated infections. Continuous bladder irrigation devices provide an avenue for managed and sterile irrigation, improving safety measures.
   
• In North America and Europe, reimbursement models typically incorporate hospital-administered CBI within comprehensive payment packages. This aids to increasing preference for conducting CBI procedures across hospitals. In addition, some regulatory bodies provide clinical guidelines which endorse CBI for the management of moderate to severe hematuria within controlled healthcare settings such as hospitals.

North America: The U.S. continuous bladder irrigation devices market is projected to grow significantly from USD 569.3 million in 2024 to USD 862.1 million by 2034.
 

• The U.S. has some of the highest incidence rates of prostate and bladder cancer in the world, especially among men aged over 65 years. The CDC indicates that in 2021, there were about 236,659 new cases of prostate cancer reported in the U.S. Postoperative care for these conditions involves ongoing bladder irrigation to avoid blood clots and ensure urinary output clarity.
   
• The growing aging population, fueled by aging baby boomers and longer life expectancy, drives long-term demand for continuous bladder irrigation systems in health care settings.
   
• For example, the U.S. Census Bureau estimates that by 2030, all baby boomers will be older than 65, making up 20% of the population, which reflects an increasing patient base in need of urological procedures.
   

Europe: The continuous bladder irrigation devices market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The UK also sees rising diagnoses of bladder and prostate cancer, mostly for men aged over 60. Cancer Research UK estimates that around 55,100 new prostate cancers are diagnosed in the UK annually. Such conditions often necessitate surgical operations such as bladder tumor resection and transurethral resection of the prostate (TURP).
   
• In the post-operative phase, continuous bladder irrigation (CBI) devices play a central role in the management of hematuria, thus are among the vital hospital equipment. The increasing disease burden across UK hospitals directly translates into the demand for CBI devices in post-operative care facilities.
   
• The NHS places evidence-based standardization at the top of post-operative care guidelines, particularly including continuous bladder irrigation for urological surgery. Such initiatives from regulatory agencies, help to curb burden across healthcare settings and drives the adoption of CBI devices.
   
• The National Institute for Health and Care Excellence (NICE) further indicated that the application of these protocols has led to a considerable reduction in readmission rates for post-operative complications in the UK.
   

Asia Pacific: Japan continuous bladder irrigation devices market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan's population, with one of the highest ratios of individuals aged 65 and older in the globe, plays an important role in the market for continuous bladder irrigation (CBI) devices.
   
• For example, based on Statista, in 2021, approximately 36.5 million Japanese people were over the age of 65 years, demonstrating an increase in age related disorders which further surged the demand for CBI devices across Japanese hospitals.
   
• Further, the Japanese health system includes comprehensive medical facilities, advanced technology infrastructure, and better physician-to-patient ratios. WHO statistics in 2021 reported that Japan had 24.1 doctors per 10,000 population, well above the world average. The systematic healthcare technology implementation in the country guarantees continued progress in CBI solutions, making it one of the crucial markets for urology medical devices.
   

Middle East and Africa: The Saudi Arabia continuous bladder irrigation devices market is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia has a growing burden of non-communicable diseases like diabetes and obesity, which are associated with urological disorders like urinary retention, bladder dysfunction, and enlargement of the prostate. The prevalence of diabetes in Saudi Arabia had increased to 17.7% in the year 2021, as per the World Health Organization (WHO).
   
• These conditions usually require surgery with post-operative continuous bladder irrigation. The increasing disease burden has driven the demand for urology care solutions such as CBI devices in Saudi Arabian hospitals.
   
• In addition, Saudi Arabia emphasizes hospital practice adherence to international accreditation and infection control standards. Continuous bladder irrigation (CBI) equipment provides treatment for hematuria and prevents clot-related complications in catheterized patients, reducing postoperative complications and hospital-acquired infections. Surgical units are increasingly incorporating these devices in their quality improvement programs, which is further aiding to the market growth.
   

Continuous Bladder Irrigation Devices Market Share

The market is segmented and controlled by a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for post-surgical procedures. Companies such as B.Braun, Baxter, Coloplast, Teleflex, and Cardinal Health are some of the dominant competitors in the market accounting for a combined market share of approximately 65%. Competition in this area arises from continuous technological developments and the ability to offer customized solutions for various surgical applications.
 

In developing nations, due to the priority given to cost, multinational companies are squeezed to offer continuous bladder irrigation devices that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinational vendors to alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.
 

Continuous Bladder Irrigation Devices Market Companies

Some of the eminent market participants operating in the continuous bladder irrigation devices industry include:

• AdvaCare
• Advin Health Care
• Angiplast
• B. Braun
• Bactiguard
• Baxter
• Boston Scientific
• C. R. Bard
• Cardinal Health
• Coloplast
• HEMC
• Medline
• Sterimed
• Teleflex
• Vogt Medical
   
• B. Braun maintains market leadership in continuous bladder irrigation (CBI) through virtue of closed irrigation systems integrated into their products. Their pre-packaged, sterile kits reduce infection risk, and their 3-way silicone Foley catheters provide long-term performance with less urethral irritation. They also offer customized irrigation products in the form of saline with antimicrobial additives, which are specific to post-surgery.
   
• Baxter has broad international distribution to hospitals and ambulatory surgical centers (ASCs) and clinical education programs. Their closed-system CBI kits include leak-proof connectors and ergonomic drainage bags, improving patient safety and nursing productivity. Their emphasis on minimized packaging waste increases its visibility in markets with high regulatory compliance.
   
• Coloplast has substantial experience in designing catheters and producing latex-free, hydrogel-coated 3-way Foley catheters which minimize allergy and provide better patient comfort. Their SpeediCath is designed to ease and speed the process of catheterization during post-operative CBI procedures.
   

The continuous bladder irrigation devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product

• Foley 3 way catheters
  • Silicone catheters
  • Latex catheters 
• Accessories
  • Irrigation set
  • Roller clamp
  • Outlet bags
• Irrigation bags

By End Use

• Hospitals
• Long term care facilities
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands 
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE